SciSight Ecosystem
SciSightAcademic Intelligence & JCR Rank
WoS SCIE Q1Subscription

Gene Therapy and Molecular Biology

Abbreviation (ISO):GENE THER MOL BIOL
Country: Greece•WoS SCIE Quartile: Q1•Identifier (ISSN):1529-9120(Print)•Articles / Year: 13
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (2021)
14

14 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
13articles/year
0% Gold OA•0% Original Research

Aims & Scope

Gene Therapy and Molecular Biology is a leading international peer-reviewed journal publishing original research, clinical updates, and reviews indexed in Clarivate Web of Science (SCIE) with Q1 quartile ranking.

Topics Covered (Recognized by AI)
Biology92.2%Genetics90.2%Biochemistry82.4%Chemistry82.4%Medicine80.4%Gene72.5%Internal medicine56.9%Cell biology33.3%Computational biology33.3%Gene expression27.5%Immunology27.5%DNA25.5%Transcription factor23.5%Cancer23.5%Chromatin21.6%Epigenetics21.6%Genetic enhancement21.6%Histone21.6%Chromatin remodeling21.6%Scaffold/matrix attachment region21.6%Cancer research21.6%
Primary Research Areas
BiologyBiochemistry & Molecular Biology
Official WebsiteNLM PubMed CatalogSubmission Portal

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Subscription
OA publishing option or traditional subscription
Publisher
Updating
Publication Language
English
Frequency
Monthly
Founding Year
1998
Editorial Address
GENE THERAPY PRESS, GREGORIOU AFXENTIOU 7, ALIMOS, ATHENS, GREECE, 17455
Indexing & Databases
PubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

10 year
YearImpact FactorArticles / YearTotal Citations
20230——
20190——
20180——
2014—17
2009—21
2008—20
2007—10
2006—14
2004—10
1999—21
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Gene Therapy and Molecular Biology

WoS Q1
00002018201920230.00
Annual Impact Factor Metric
2023:0

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Cell
IF: 45.1Q1
60% MatchExplore →
60% MatchExplore →
60% MatchExplore →
Record UUID: 76f4c756-e76e-4e41-93fd-b5e348d51c5b
Database Updated: 2026-09-28